Search research articles
Contact Us
Filters
Showing results (201-210 of 259) with videos related to
Page
of 26
Sort By:
Annals of Hematology
|
December 14, 2019
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice
Massimo Breccia, Claudia Baratè, Giulia Benevolo, et al.
Blood Transfusion = Trasfusione Del Sangue
|
November 13, 2018
Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus
Mariasanta Napolitano, Giorgia Saccullo, Marco Marietta, et al.
Blood Cancer Journal
|
August 6, 2025
Neutrophil-to-Lymphocyte ratio as surrogate for JAK2<sup>V617F</sup> suppression and event-free survival in polycythemia vera
Tiziano Barbui, Arianna Ghirardi, Victoria Empson, et al.
Annals of Hematology
|
June 16, 2019
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis
Massimo Breccia, Luigiana Luciano, Novella Pugliese, et al.
Leukemia
|
May 28, 2025
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea
Francesca Palandri, Massimo Breccia, Elena M Elli, et al.
Journal of Medical Genetics
|
January 9, 2007
13q Deletion and central nervous system anomalies: further insights from karyotype-phenotype analyses of 14 patients
Lucia Ballarati, Elena Rossi, Maria Teresa Bonati, et al.
British Journal of Haematology
|
December 18, 2012
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients
Tommaso Za, Valerio De Stefano, Elena Rossi, et al.
American Journal of Hematology
|
January 7, 2010
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia
Valerio De Stefano, Tommaso Za, Elena Rossi, et al.
Annals of Hematology
|
July 8, 2009
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation
Valerio De Stefano, Tommaso Za, Elena Rossi, et al.
Annals of Hematology
|
October 11, 2025
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience
Angela Rago, Francesca Fioritoni, Carmine Liberatore, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 259) with videos related to
Sort By:
Page
of 26
Annals of Hematology
|
December 14, 2019
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice
Massimo Breccia, Claudia Baratè, Giulia Benevolo, et al.
Blood Transfusion = Trasfusione Del Sangue
|
November 13, 2018
Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus
Mariasanta Napolitano, Giorgia Saccullo, Marco Marietta, et al.
Blood Cancer Journal
|
August 6, 2025
Neutrophil-to-Lymphocyte ratio as surrogate for JAK2<sup>V617F</sup> suppression and event-free survival in polycythemia vera
Tiziano Barbui, Arianna Ghirardi, Victoria Empson, et al.
Annals of Hematology
|
June 16, 2019
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis
Massimo Breccia, Luigiana Luciano, Novella Pugliese, et al.
Leukemia
|
May 28, 2025
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea
Francesca Palandri, Massimo Breccia, Elena M Elli, et al.
Journal of Medical Genetics
|
January 9, 2007
13q Deletion and central nervous system anomalies: further insights from karyotype-phenotype analyses of 14 patients
Lucia Ballarati, Elena Rossi, Maria Teresa Bonati, et al.
British Journal of Haematology
|
December 18, 2012
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients
Tommaso Za, Valerio De Stefano, Elena Rossi, et al.
American Journal of Hematology
|
January 7, 2010
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia
Valerio De Stefano, Tommaso Za, Elena Rossi, et al.
Annals of Hematology
|
July 8, 2009
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation
Valerio De Stefano, Tommaso Za, Elena Rossi, et al.
Annals of Hematology
|
October 11, 2025
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience
Angela Rago, Francesca Fioritoni, Carmine Liberatore, et al.
Page
of 26